glp-1 dual agonist Trends in the Development of Receptor Agonists Tirzepatide, a dual GIP/GLP-1 receptor
Description
semaglutide is taken weekly, produces greater results, but is pricier and more likely to cause GI side effects
Use of dipeptidyl peptidase-4 inhibitors for type 2 diabetes mellitus and risk of fracture
9,295 Views 85 Download 1 Crossref ABSTRACT Obesity is a disease requiring treatment
Mahmud N, Panchal S, Abu-Gazala S, Serper M, Lewis JD, Kaplan DE
